Cargando…
Designing and interpreting the results of first-time-to-man studies
First human administration of a new chemical entity (NCE) constitutes a critical step in drug development. The primary objective of such a study is the assessment of the shortterm safety and tolerability of single and multiple doses of the NCE in healthy volunteers. Secondary objectives are to obtai...
Autor principal: | Patat, Alain A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181605/ https://www.ncbi.nlm.nih.gov/pubmed/22033693 |
Ejemplares similares
-
Studies in schizophrenia: pathophysiology and treatment
por: Tamminga, Carol A., et al.
Publicado: (2002) -
Dopamine in the history of the schizophrenic brain: recent contributions of brain-imaging studies
por: Lamelle, Marc, et al.
Publicado: (2000) -
Psychostimulants in the therapy of treatment-resistant depression Review of the literature and findings from a retrospective study in 65 depressed patients
por: Stotz, Gabriele, et al.
Publicado: (1999) -
Treatment mechanisms: traditional and new antipsychotic drugs
por: Tamminga, Carol A.
Publicado: (2000) -
Psychiatric pharmacogenomic testing in clinical practice
por: Mrazek, David A.
Publicado: (2010)